Home › Breast Cancer › NCT02250352
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Core Biopsies of Breast Tumor Tissue Repository
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Known or suspected breast cancer * Known or suspected metastatic solid tumor that originated in the breast per the patient's medical history Exclusion Criteria: * Inability to sign informed consent * Known bleeding disorder * Use of anticoagulant medications (heparin, warfarin, etc.) within one week prior to biopsy * Use of antiplatelet medications (aspirin, clopidogrel, etc.) within one week prior to biopsy
About the study
This research trial establishes a breast tumor tissue repository from core biopsies. Collecting breast tissue from core biopsies may allow doctors to learn more about the biology of breast cancer and to analyze proteins, genes, and other components of tumor cells. It may also allow doctors to conduct future studies to help understand how breast cancer grows and how it responds to different types of therapy. This will help doctors develop better breast cancer therapies and better tests to help make treatment decisions.
What is being tested
- cytology specimen collection procedure (other)
Sponsor: University of Southern California · Participants: 400 · Started: Nov 14, 2013
Contact the study team
- Zeno Ashai · Phone: 323-865-0463
Official record on ClinicalTrials.gov — NCT02250352
Locations in the U.S.
| California | USC Norris Comprehensive Cancer Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.